SPONSOR
Wright State University
Total Trials
2
Recruiting
2
Phases
Phase 1
Conditions studied: Actinic KeratosesAgingNon-Melanoma Skin CancerPhotosensitivityMicrovesicle Particle
Wright State University is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Actinic Keratoses, Aging, Non-Melanoma Skin Cancer, Photosensitivity.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Wright State University
How many clinical trials has Wright State University sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Wright State University, of which 2 are actively recruiting participants. These trials cover conditions including Actinic Keratoses, Aging, Non-Melanoma Skin Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Wright State University research focus on?
Wright State University clinical trials span Actinic Keratoses, Aging, Non-Melanoma Skin Cancer, Photosensitivity, Microvesicle Particle. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Wright State University clinical trial?
To participate in a Wright State University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Wright State University trials with current recruitment status updated daily.
Clinical Trials by Wright State University
NCT06428721
Recruiting
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
Actinic Keratoses
NCT04520217 Phase 1
Recruiting
Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
Photosensitivity
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology